Questions about inflammatory diseases
Does targeting ISG15 help with skin inflammatory diseases?
Targeting the ISG15 pathway shows potential for treating skin inflammatory diseases because ISG15 can act as a cytokine that worsens inflammation, but current research is mostly theoretical.
Full answer →Can marine sponge compounds treat infections and inflammatory diseases?
Marine sponge compounds show promise for treating infections and inflammatory diseases, with specific examples like manzamines for malaria and diketopiperazines for sepsis.
Full answer →All inflammatory diseases Articles
- Herbal medicines and phytoconstituents modulate vagus nerve activity and cholinergic neurotransmission in animal models
- Quercetin immunity research surges, mapping review finds 12 thematic clusters
- Aberrant IgG glycosylation correlates with cancer progression and serves as a novel aging-associated factor
- TET2 functions as a tumor suppressor in myeloid malignancies and immunomodulator in solid tumors
- Acidic microenvironments reprogram immune cells via pH sensors, driving tissue injury
- Transcutaneous Vagus Nerve Stimulation utilizes distinct auricular and cervical pathways for non-invasive treatment applications
- Narrative review discusses paradoxical inflammatory reactions in pediatric patients receiving biologic therapy
- Molecular review explores Siglec signaling pathways in cancer and inflammatory disorders
- Narrative review outlines sialidase biology roadmap for genetic syndromes and inflammatory disorders
- Narrative review advocates multi-omics models to clarify exercise associations
- Integrative review of Tedania sponge compounds for cancer and infections
- Retrospective FAERS analysis reveals sex-specific adverse event patterns for apremilast, crisaborole, and roflumilast in chronic inflammatory diseases
- Review of ISG15 pathway targeting for inflammatory and cardiovascular diseases